| 发明名称 |
ACELLULAR PERTUSSIS VACCINE |
| 摘要 |
Described are acellular pertussis (aP) vaccine compositions comprising Bordetella pertussis antigens pertussis toxoid (PT), filamentous hemagglutinin (FHA), and fimbriae types 2 and 3 (FIM), and optionally pertactin (PRN), wherein FIM is present in an amount of 12-100 μg per human dose. |
| 申请公布号 |
US2015086586(A1) |
申请公布日期 |
2015.03.26 |
| 申请号 |
US201414558641 |
申请日期 |
2014.12.02 |
| 申请人 |
Crucell Holland B.V. |
发明人 |
POOLMAN Jan Theunis |
| 分类号 |
A61K39/02;C07K14/235 |
主分类号 |
A61K39/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An acellular pertussis (aP) immunogenic composition
comprising:
Bordetella pertussis toxoid (PT),Bordetella pertussis-filamentous hemagglutinin (FHA), andunconjugated Bordetella pertussis fimbriae types 2 and 3 (FIM), wherein FIM is present in the composition in an amount of 12-100 μg per human dose. |
| 地址 |
Leiden NL |
